ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
179.97
5.07
(2.90%)
Closed 29 June 6:00AM
179.97
0.00
(0.00%)
After Hours: 7:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
179.97
Bid
-
Offer
-
Volume
750,545
173.815 Day's Range 181.2899
170.59 52 Week Range 348.67
Market Cap
Previous Close
174.90
Open
176.16
Last Trade Time
Financial Volume
US$ 133,840,607
VWAP
178.3246
Average Volume (3m)
332,585
Shares Outstanding
38,764,917
Dividend Yield
-
PE Ratio
76.69
Earnings Per Share (EPS)
2.35
Revenue
1.06B
Net Profit
90.95M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Dover, Delaware, USA
Founded
1970
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was US$174.90. Over the last year, Penumbra shares have traded in a share price range of US$ 170.59 to US$ 348.67.

Penumbra currently has 38,764,917 shares in issue. The market capitalisation of Penumbra is US$6.98 billion. Penumbra has a price to earnings ratio (PE ratio) of 76.69.

Penumbra (PEN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-63k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

PEN Latest News

Penumbra, Inc. to Present at the Truist Securities MedTech Conference

Penumbra, Inc. to Present at the Truist Securities MedTech Conference PR Newswire ALAMEDA, Calif., June 4, 2024 ALAMEDA, Calif., June 4, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today...

Penumbra, Inc. to Present at the William Blair Growth Stock Conference

Penumbra, Inc. to Present at the William Blair Growth Stock Conference PR Newswire ALAMEDA, Calif., May 23, 2024 ALAMEDA, Calif., May 23, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
13.221.82178217822176.75181.2899171.1345624175.39383217CS
4-8.58-4.55051710422188.55198.61170.59374361184.55239363CS
12-36.3-16.784574837216.27226.27170.59332585198.02029276CS
26-79.48-30.6340335325259.45277.34170.59341846222.07795556CS
52-147.16-44.9851740898327.13348.67170.59372041236.3664981CS
156-105.18-36.8858495529285.15348.67114.865312979226.60986099CS
26018.9911.7964964592160.98348.67107.5356586212.78896557CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LDROLode Resources Ltd
AUD 0.005
(400.00%)
49.26k
TKMOTrek Metals Limited
AUD 0.002
(100.00%)
277.78k
IBGOIronbark Zinc Limited
AUD 0.002
(100.00%)
1.25M
BFCBeston Global Food Company Limited
AUD 0.003
(50.00%)
8.94M
TD1Tali Digital Limited
AUD 0.0015
(50.00%)
1.05M
RAGORagnar Metals Limited
AUD 0.001
(-75.00%)
1M
ACMOAAustralian Critical Minerals Ltd
AUD 0.013
(-56.67%)
45k
AEVOAvenira Limited
AUD 0.001
(-50.00%)
3M
GRLOGodolphin Resources Limited
AUD 0.001
(-50.00%)
3M
HYTOHyTerra Ltd
AUD 0.011
(-35.29%)
1.2M
PENPeninsula Energy Ltd
AUD 0.1025
(0.00%)
77.12M
SYASayona Mining Limited
AUD 0.036
(-2.70%)
59.44M
ADNAndromeda Metals Limited
AUD 0.016
(-11.11%)
49.06M
IMUImugene Limited
AUD 0.057
(5.56%)
45.01M
SGRStar Entertainment Group Limited
AUD 0.50
(2.56%)
40.45M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 years ago
IPO should be out soon.
no symbol yet.
👍️0